<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on September 20, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/ct2/show/NCT02244892</url>
  </required_header>
  <id_info>
    <org_study_id>IRB 04-14-30</org_study_id>
    <nct_id>NCT02244892</nct_id>
  </id_info>
  <brief_title>Correlation of Scheimpflug Densitometry Measurements of Corneal Haze With Disability Glare</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospitals Cleveland Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospitals Cleveland Medical Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Disability glare is described as &quot;halos&quot; or &quot;starbursts&quot; around bright sources of light that&#xD;
      can cause discomfort and reduce vision. The cornea is the clear &quot;window&quot; at the front of the&#xD;
      eye, but certain conditions such as a previous infection can leave a scar. Corneal scars can&#xD;
      cause disability glare by scattering and spreading incoming light instead of allowing it to&#xD;
      focus on the back of the eye (retina) to get a crisp image. In this study, the corneal scar&#xD;
      will be analyzed using a new device that measures scar density (Pentacam), and a relationship&#xD;
      with disability glare will be made. This can help us further understand disability glare and&#xD;
      make better decisions in the future on when to treat these scars to help patients see better.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Disability glare is a phenomenon commonly described as starbursts and halos that results in&#xD;
      difficulty seeing clearly in the presence of bright &quot;blinding&quot; light. It can appear as if a&#xD;
      veil of light is cast over the world outside. Optically, this occurs when incoming light is&#xD;
      scattered in the eye instead of being focused on the retina. This is called straylight, and&#xD;
      it diffusely illuminates the retina which causes desensitization of the photoreceptors and&#xD;
      reduces the contrast of the retinal image (Lombardo &amp; Lombardo, 2010). The main sources of&#xD;
      scatter in the human eye are opacities in the clear ocular media, primarily due to diffusion&#xD;
      and loss of transparency in the cornea and lens, as well as within the retina. While the lens&#xD;
      is the largest contributor to light scatter (especially with cataract formation and aging),&#xD;
      opacification of the cornea (e.g. scars or haze) can similarly cause intraocular light&#xD;
      scattering, resulting in disability glare and decreased contrast sensitivity (Fan-Paul et&#xD;
      al., 2002).&#xD;
&#xD;
      Due to the subjective nature of disability glare and contrast sensitivity, it is fairly&#xD;
      difficult to develop a reliable objective way to measure and quantify this phenomenon. One of&#xD;
      the most commonly used clinical tests for disability glare is the Brightness Acuity Tester&#xD;
      (BAT), which is described as an ice cream scooper 60 mm in diameter with a 12 mm hole in the&#xD;
      center. With the patient viewing a visual acuity chart through the hole, a uniform luminance&#xD;
      at three different settings-high (white sand beach), medium (clear day), low (overhead&#xD;
      lighting)-is used to induce glare and simulate the various real-life conditions. The drop in&#xD;
      visual acuity with the various glare settings is used as a measure of disability glare. The&#xD;
      BAT test has been found to be a reliable predictor of outdoor visual acuity (clinically&#xD;
      validated for use in measuring disability glare secondary to cataracts), is ubiquitously&#xD;
      available, and is easy to administer. To further and more accurately reflect real life&#xD;
      situations, it can be used in conjunction with a contrast sensitivity chart rather than the&#xD;
      regular black-on-white Snellen letter chart (Aslam et al., 2007). Contrast sensitivity can be&#xD;
      tested using letter-based charts (e.g. Pelli-Robson letter sensitivity chart) that consist of&#xD;
      letters of the same size but with decreasing contrast, or contrast gratings, which are based&#xD;
      on sinusoidal waves of light (e.g. Vistech MCT-8000 or FACT).&#xD;
&#xD;
      Opacification of the cornea in the form of scars or haze is a natural response to a wide&#xD;
      array of pathological insults (e.g. infection, degeneration, corneal dystrophies) and can&#xD;
      result in light scatter and glare. Measurement of corneal haze was previously crudely&#xD;
      performed via standard slit-lamp examination and human measurement. Recently, an automated,&#xD;
      non-invasive, and objective method to measure corneal scar density was introduced using&#xD;
      Scheimpflug imaging. This Pentacam device (Oculus Optikgerate GmbH, Wetzlar, Germany)&#xD;
      consists of a rotating camera that captures images of the cornea at an angle, and analysis of&#xD;
      these anterior segment images can be employed to quantify scattered light in various&#xD;
      diameters and depths of the cornea. The generated maps of the amount of scatter in different&#xD;
      regions of the cornea are called corneal densitometry maps, and they are displayed along with&#xD;
      maps of corneal topography (elevation) and pachymetry (thickness). Normative values for&#xD;
      Scheimpflug densitometry have recently been established (Dhubhghaill et al., 2013).&#xD;
      Measurements have also been obtained after various surgical procedures to analyze their&#xD;
      impact on corneal clarity. This includes analysis of corneas after refractive surgery such as&#xD;
      LASIK (Cennamo et al., 2011; Fares et al., 2012) and PRK (Takacs et al., 2011), as well as&#xD;
      various forms of corneal transplantation (Koh et al., 2012; Bhatt et al., 2012;&#xD;
      Arnalich-Montiel et al., 2013; Ivarsen &amp; Hjortdal, 2013) and collagen cross-linking&#xD;
      (Gutierrez et al., 2012; Greenstein et al., 2010). Furthermore, it has been used to&#xD;
      characterize pathological conditions including infectious keratitis (Otri et al., 2012;&#xD;
      Orucoglu et al., 2014) and congenital corneal opacities (Elfein et al., 2013). However, no&#xD;
      functional correlation has been made with these anatomical maps, and the relationship between&#xD;
      scattered light as measured by densitometry and its effect on visual function such as&#xD;
      contrast sensitivity and disability glare has not been well-characterized.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Recruitment&#xD;
  </why_stopped>
  <start_date>September 2014</start_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Disability glare</measure>
    <time_frame>1 year</time_frame>
    <description>BAT measurements of disability glare</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual quality</measure>
    <time_frame>1 year</time_frame>
    <description>NEI-VFQ25 questionnaire on functional visual quality</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Contrast sensitivity</measure>
    <time_frame>1 year</time_frame>
    <description>Vistech contrast grating test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual acuity</measure>
    <time_frame>1 year</time_frame>
    <description>Visual acuity measured by Snellen chart</description>
  </primary_outcome>
  <enrollment type="Actual">0</enrollment>
  <condition>Vision Disability</condition>
  <eligibility>
    <study_pop>
      <textblock>
        This will be a prospective study in which all eligible and willing patients will undergo&#xD;
        the same workup. The expected duration is 1 year, and the trial will be stopped once the&#xD;
        needed number of subjects has been enrolled. Testing will be performed on the day of the&#xD;
        routine clinical visit and will only extend the appointment by less than 30 minutes.&#xD;
&#xD;
        All patients receiving ophthalmological care at University Hospitals (both at the main Case&#xD;
        Medical Center site and the satellite offices at Westlake and Landerbrook) who meet the&#xD;
        inclusion and exclusion criteria would be eligible for this study. Subjects will be&#xD;
        identified who have an isolated corneal scar in one eye and otherwise healthy eyes with no&#xD;
        clinical evidence of lens or retinal pathology. Patients will be enrolled between September&#xD;
        6, 2014 and September 5, 2015, with the goal of recruiting at least 80-100 subjects.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18 years or greater&#xD;
&#xD;
          -  Presence of corneal scar in one eye&#xD;
&#xD;
          -  No clinical evidence of any other intraocular pathology&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Clinical evidence of other ocular pathology (e.g. cataracts)&#xD;
&#xD;
          -  Pediatric patients less than 18 years old&#xD;
&#xD;
          -  Bilateral corneal pathology&#xD;
&#xD;
          -  Presence of active corneal inflammation/infection&#xD;
&#xD;
          -  Presence of degenerative corneal disease&#xD;
&#xD;
          -  History of prior corneal surgery (e.g. corneal graft)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Hospitals Case Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Fan-Paul NI, Li J, Miller JS, Florakis GJ. Night vision disturbances after corneal refractive surgery. Surv Ophthalmol. 2002 Nov-Dec;47(6):533-46. doi: 10.1016/s0039-6257(02)00350-8.</citation>
    <PMID>12504738</PMID>
  </reference>
  <reference>
    <citation>Aslam TM, Haider D, Murray IJ. Principles of disability glare measurement: an ophthalmological perspective. Acta Ophthalmol Scand. 2007 Jun;85(4):354-60. doi: 10.1111/j.1600-0420.2006.00860.x. Epub 2007 Feb 20.</citation>
    <PMID>17313443</PMID>
  </reference>
  <reference>
    <citation>Lombardo M, Lombardo G. Wave aberration of human eyes and new descriptors of image optical quality and visual performance. J Cataract Refract Surg. 2010 Feb;36(2):313-31. doi: 10.1016/j.jcrs.2009.09.026.</citation>
    <PMID>20152616</PMID>
  </reference>
  <reference>
    <citation>Ni Dhubhghaill S, Rozema JJ, Jongenelen S, Ruiz Hidalgo I, Zakaria N, Tassignon MJ. Normative values for corneal densitometry analysis by Scheimpflug optical assessment. Invest Ophthalmol Vis Sci. 2014 Jan 7;55(1):162-8. doi: 10.1167/iovs.13-13236.</citation>
    <PMID>24327608</PMID>
  </reference>
  <reference>
    <citation>Cennamo G, Forte R, Aufiero B, La Rana A. Computerized Scheimpflug densitometry as a measure of corneal optical density after excimer laser refractive surgery in myopic eyes. J Cataract Refract Surg. 2011 Aug;37(8):1502-6. doi: 10.1016/j.jcrs.2011.03.037.</citation>
    <PMID>21782093</PMID>
  </reference>
  <reference>
    <citation>Fares U, Otri AM, Al-Aqaba MA, Faraj L, Dua HS. Wavefront-optimized excimer laser in situ keratomileusis for myopia and myopic astigmatism: refractive outcomes and corneal densitometry. J Cataract Refract Surg. 2012 Dec;38(12):2131-8. doi: 10.1016/j.jcrs.2012.07.041. Epub 2012 Oct 18.</citation>
    <PMID>23084157</PMID>
  </reference>
  <reference>
    <citation>Takacs AI, Mihaltz K, Nagy ZZ. Corneal density with the Pentacam after photorefractive keratectomy. J Refract Surg. 2011 Apr;27(4):269-77. doi: 10.3928/1081597X-20100618-02. Epub 2010 Jul 1.</citation>
    <PMID>20672772</PMID>
  </reference>
  <reference>
    <citation>Koh S, Maeda N, Nakagawa T, Nishida K. Quality of vision in eyes after selective lamellar keratoplasty. Cornea. 2012 Nov;31 Suppl 1:S45-9. doi: 10.1097/ICO.0b013e318269c9cd.</citation>
    <PMID>23038035</PMID>
  </reference>
  <reference>
    <citation>Bhatt UK, Fares U, Rahman I, Said DG, Maharajan SV, Dua HS. Outcomes of deep anterior lamellar keratoplasty following successful and failed 'big bubble'. Br J Ophthalmol. 2012 Apr;96(4):564-9. doi: 10.1136/bjophthalmol-2011-300214. Epub 2011 Dec 1.</citation>
    <PMID>22133987</PMID>
  </reference>
  <reference>
    <citation>Arnalich-Montiel F, Hernandez-Verdejo JL, Oblanca N, Munoz-Negrete FJ, De Miguel MP. Comparison of corneal haze and visual outcome in primary DSAEK versus DSAEK following failed DMEK. Graefes Arch Clin Exp Ophthalmol. 2013 Nov;251(11):2575-84. doi: 10.1007/s00417-013-2460-y. Epub 2013 Sep 6.</citation>
    <PMID>24008847</PMID>
  </reference>
  <reference>
    <citation>Ivarsen A, Hjortdal J. Recipient corneal thickness and visual outcome after Descemet's stripping automated endothelial keratoplasty. Br J Ophthalmol. 2014 Jan;98(1):30-4. doi: 10.1136/bjophthalmol-2013-304042. Epub 2013 Oct 16.</citation>
    <PMID>24133026</PMID>
  </reference>
  <reference>
    <citation>Gutierrez R, Lopez I, Villa-Collar C, Gonzalez-Meijome JM. Corneal transparency after cross-linking for keratoconus: 1-year follow-up. J Refract Surg. 2012 Nov;28(11):781-6. doi: 10.3928/1081597X-20121011-06.</citation>
    <PMID>23347372</PMID>
  </reference>
  <reference>
    <citation>Greenstein SA, Fry KL, Bhatt J, Hersh PS. Natural history of corneal haze after collagen crosslinking for keratoconus and corneal ectasia: Scheimpflug and biomicroscopic analysis. J Cataract Refract Surg. 2010 Dec;36(12):2105-14. doi: 10.1016/j.jcrs.2010.06.067.</citation>
    <PMID>21111314</PMID>
  </reference>
  <reference>
    <citation>Otri AM, Fares U, Al-Aqaba MA, Dua HS. Corneal densitometry as an indicator of corneal health. Ophthalmology. 2012 Mar;119(3):501-8. doi: 10.1016/j.ophtha.2011.08.024. Epub 2011 Nov 30.</citation>
    <PMID>22133793</PMID>
  </reference>
  <reference>
    <citation>Elflein HM, Hofherr T, Berisha-Ramadani F, Weyer V, Lampe C, Beck M, Pitz S. Measuring corneal clouding in patients suffering from mucopolysaccharidosis with the Pentacam densitometry programme. Br J Ophthalmol. 2013 Jul;97(7):829-33. doi: 10.1136/bjophthalmol-2012-302913. Epub 2013 May 17.</citation>
    <PMID>23685998</PMID>
  </reference>
  <verification_date>April 2022</verification_date>
  <study_first_submitted>September 17, 2014</study_first_submitted>
  <study_first_submitted_qc>September 17, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 19, 2014</study_first_posted>
  <last_update_submitted>April 5, 2022</last_update_submitted>
  <last_update_submitted_qc>April 5, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Disability glare</keyword>
  <keyword>Corneal scar</keyword>
  <keyword>Corneal haze</keyword>
  <keyword>Scheimpflug densitometry</keyword>
  <keyword>Contrast sensitivity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vision Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>


download date: ClinicalTrials.gov processed this data on September 20, 2023
link text: Link to the current ClinicalTrials.gov record.
url: https://clinicaltrials.gov/ct2/show/NCT02244892
org study id: IRB 04-14-30
nct id: NCT02244892
lead sponsor: 
is fda regulated drug: No
is fda regulated device: No
Disability glare is described as "halos" or "starbursts" around bright sources of light that
      can cause discomfort and reduce vision. The cornea is the clear "window" at the front of the
      eye, but certain conditions such as a previous infection can leave a scar. Corneal scars can
      cause disability glare by scattering and spreading incoming light instead of allowing it to
      focus on the back of the eye (retina) to get a crisp image. In this study, the corneal scar
      will be analyzed using a new device that measures scar density (Pentacam), and a relationship
      with disability glare will be made. This can help us further understand disability glare and
      make better decisions in the future on when to treat these scars to help patients see better.
Disability glare is a phenomenon commonly described as starbursts and halos that results in
      difficulty seeing clearly in the presence of bright "blinding" light. It can appear as if a
      veil of light is cast over the world outside. Optically, this occurs when incoming light is
      scattered in the eye instead of being focused on the retina. This is called straylight, and
      it diffusely illuminates the retina which causes desensitization of the photoreceptors and
      reduces the contrast of the retinal image (Lombardo & Lombardo, 2010). The main sources of
      scatter in the human eye are opacities in the clear ocular media, primarily due to diffusion
      and loss of transparency in the cornea and lens, as well as within the retina. While the lens
      is the largest contributor to light scatter (especially with cataract formation and aging),
      opacification of the cornea (e.g. scars or haze) can similarly cause intraocular light
      scattering, resulting in disability glare and decreased contrast sensitivity (Fan-Paul et
      al., 2002).

      Due to the subjective nature of disability glare and contrast sensitivity, it is fairly
      difficult to develop a reliable objective way to measure and quantify this phenomenon. One of
      the most commonly used clinical tests for disability glare is the Brightness Acuity Tester
      (BAT), which is described as an ice cream scooper 60 mm in diameter with a 12 mm hole in the
      center. With the patient viewing a visual acuity chart through the hole, a uniform luminance
      at three different settings-high (white sand beach), medium (clear day), low (overhead
      lighting)-is used to induce glare and simulate the various real-life conditions. The drop in
      visual acuity with the various glare settings is used as a measure of disability glare. The
      BAT test has been found to be a reliable predictor of outdoor visual acuity (clinically
      validated for use in measuring disability glare secondary to cataracts), is ubiquitously
      available, and is easy to administer. To further and more accurately reflect real life
      situations, it can be used in conjunction with a contrast sensitivity chart rather than the
      regular black-on-white Snellen letter chart (Aslam et al., 2007). Contrast sensitivity can be
      tested using letter-based charts (e.g. Pelli-Robson letter sensitivity chart) that consist of
      letters of the same size but with decreasing contrast, or contrast gratings, which are based
      on sinusoidal waves of light (e.g. Vistech MCT-8000 or FACT).

      Opacification of the cornea in the form of scars or haze is a natural response to a wide
      array of pathological insults (e.g. infection, degeneration, corneal dystrophies) and can
      result in light scatter and glare. Measurement of corneal haze was previously crudely
      performed via standard slit-lamp examination and human measurement. Recently, an automated,
      non-invasive, and objective method to measure corneal scar density was introduced using
      Scheimpflug imaging. This Pentacam device (Oculus Optikgerate GmbH, Wetzlar, Germany)
      consists of a rotating camera that captures images of the cornea at an angle, and analysis of
      these anterior segment images can be employed to quantify scattered light in various
      diameters and depths of the cornea. The generated maps of the amount of scatter in different
      regions of the cornea are called corneal densitometry maps, and they are displayed along with
      maps of corneal topography (elevation) and pachymetry (thickness). Normative values for
      Scheimpflug densitometry have recently been established (Dhubhghaill et al., 2013).
      Measurements have also been obtained after various surgical procedures to analyze their
      impact on corneal clarity. This includes analysis of corneas after refractive surgery such as
      LASIK (Cennamo et al., 2011; Fares et al., 2012) and PRK (Takacs et al., 2011), as well as
      various forms of corneal transplantation (Koh et al., 2012; Bhatt et al., 2012;
      Arnalich-Montiel et al., 2013; Ivarsen & Hjortdal, 2013) and collagen cross-linking
      (Gutierrez et al., 2012; Greenstein et al., 2010). Furthermore, it has been used to
      characterize pathological conditions including infectious keratitis (Otri et al., 2012;
      Orucoglu et al., 2014) and congenital corneal opacities (Elfein et al., 2013). However, no
      functional correlation has been made with these anatomical maps, and the relationship between
      scattered light as measured by densitometry and its effect on visual function such as
      contrast sensitivity and disability glare has not been well-characterized.
observational model: Case-Only
time perspective: Cross-Sectional
measure: Disability glare
time frame: 1 year
description: BAT measurements of disability glare
measure: Visual quality
time frame: 1 year
description: NEI-VFQ25 questionnaire on functional visual quality
measure: Contrast sensitivity
time frame: 1 year
description: Vistech contrast grating test
measure: Visual acuity
time frame: 1 year
description: Visual acuity measured by Snellen chart
study pop: 
sampling method: Non-Probability Sample
criteria: 
gender: All
minimum age: 18 Years
maximum age: N/A
healthy volunteers: No
facility: 
country: United States
citation: Fan-Paul NI, Li J, Miller JS, Florakis GJ. Night vision disturbances after corneal refractive surgery. Surv Ophthalmol. 2002 Nov-Dec;47(6):533-46. doi: 10.1016/s0039-6257(02)00350-8.
PMID: 12504738
citation: Aslam TM, Haider D, Murray IJ. Principles of disability glare measurement: an ophthalmological perspective. Acta Ophthalmol Scand. 2007 Jun;85(4):354-60. doi: 10.1111/j.1600-0420.2006.00860.x. Epub 2007 Feb 20.
PMID: 17313443
citation: Lombardo M, Lombardo G. Wave aberration of human eyes and new descriptors of image optical quality and visual performance. J Cataract Refract Surg. 2010 Feb;36(2):313-31. doi: 10.1016/j.jcrs.2009.09.026.
PMID: 20152616
citation: Ni Dhubhghaill S, Rozema JJ, Jongenelen S, Ruiz Hidalgo I, Zakaria N, Tassignon MJ. Normative values for corneal densitometry analysis by Scheimpflug optical assessment. Invest Ophthalmol Vis Sci. 2014 Jan 7;55(1):162-8. doi: 10.1167/iovs.13-13236.
PMID: 24327608
citation: Cennamo G, Forte R, Aufiero B, La Rana A. Computerized Scheimpflug densitometry as a measure of corneal optical density after excimer laser refractive surgery in myopic eyes. J Cataract Refract Surg. 2011 Aug;37(8):1502-6. doi: 10.1016/j.jcrs.2011.03.037.
PMID: 21782093
citation: Fares U, Otri AM, Al-Aqaba MA, Faraj L, Dua HS. Wavefront-optimized excimer laser in situ keratomileusis for myopia and myopic astigmatism: refractive outcomes and corneal densitometry. J Cataract Refract Surg. 2012 Dec;38(12):2131-8. doi: 10.1016/j.jcrs.2012.07.041. Epub 2012 Oct 18.
PMID: 23084157
citation: Takacs AI, Mihaltz K, Nagy ZZ. Corneal density with the Pentacam after photorefractive keratectomy. J Refract Surg. 2011 Apr;27(4):269-77. doi: 10.3928/1081597X-20100618-02. Epub 2010 Jul 1.
PMID: 20672772
citation: Koh S, Maeda N, Nakagawa T, Nishida K. Quality of vision in eyes after selective lamellar keratoplasty. Cornea. 2012 Nov;31 Suppl 1:S45-9. doi: 10.1097/ICO.0b013e318269c9cd.
PMID: 23038035
citation: Bhatt UK, Fares U, Rahman I, Said DG, Maharajan SV, Dua HS. Outcomes of deep anterior lamellar keratoplasty following successful and failed 'big bubble'. Br J Ophthalmol. 2012 Apr;96(4):564-9. doi: 10.1136/bjophthalmol-2011-300214. Epub 2011 Dec 1.
PMID: 22133987
citation: Arnalich-Montiel F, Hernandez-Verdejo JL, Oblanca N, Munoz-Negrete FJ, De Miguel MP. Comparison of corneal haze and visual outcome in primary DSAEK versus DSAEK following failed DMEK. Graefes Arch Clin Exp Ophthalmol. 2013 Nov;251(11):2575-84. doi: 10.1007/s00417-013-2460-y. Epub 2013 Sep 6.
PMID: 24008847
citation: Ivarsen A, Hjortdal J. Recipient corneal thickness and visual outcome after Descemet's stripping automated endothelial keratoplasty. Br J Ophthalmol. 2014 Jan;98(1):30-4. doi: 10.1136/bjophthalmol-2013-304042. Epub 2013 Oct 16.
PMID: 24133026
citation: Gutierrez R, Lopez I, Villa-Collar C, Gonzalez-Meijome JM. Corneal transparency after cross-linking for keratoconus: 1-year follow-up. J Refract Surg. 2012 Nov;28(11):781-6. doi: 10.3928/1081597X-20121011-06.
PMID: 23347372
citation: Greenstein SA, Fry KL, Bhatt J, Hersh PS. Natural history of corneal haze after collagen crosslinking for keratoconus and corneal ectasia: Scheimpflug and biomicroscopic analysis. J Cataract Refract Surg. 2010 Dec;36(12):2105-14. doi: 10.1016/j.jcrs.2010.06.067.
PMID: 21111314
citation: Otri AM, Fares U, Al-Aqaba MA, Dua HS. Corneal densitometry as an indicator of corneal health. Ophthalmology. 2012 Mar;119(3):501-8. doi: 10.1016/j.ophtha.2011.08.024. Epub 2011 Nov 30.
PMID: 22133793
citation: Elflein HM, Hofherr T, Berisha-Ramadani F, Weyer V, Lampe C, Beck M, Pitz S. Measuring corneal clouding in patients suffering from mucopolysaccharidosis with the Pentacam densitometry programme. Br J Ophthalmol. 2013 Jul;97(7):829-33. doi: 10.1136/bjophthalmol-2012-302913. Epub 2013 May 17.
PMID: 23685998
responsible party type: Sponsor
mesh term: Vision Disorders